Top

Published in:

01-03-2017 | Editorial

Should all patients with sepsis receive anticoagulation? Yes

Authors: Ferhat Meziani, Satoshi Gando, Jean-Louis Vincent

Published in: Intensive Care Medicine | Issue 3/2017

Excerpt

Sepsis is invariably associated with activation of blood coagulation owing to excessive thrombin formation, defective fibrinolysis and defective natural anticoagulants, resulting in fibrin deposits and ultimately in disseminated intravascular coagulation (DIC) [1]. Furthermore, as a result of microvascular thrombosis, sepsis-induced coagulopathy has been associated with multiple organ dysfunction syndrome and a poor prognosis [2]. This represents the basis for anticoagulation in all patients with sepsis. …

Gando S, Meziani F, Levi M (2016) What’s new in the diagnostic criteria of disseminated intravascular coagulation? Intensive Care Med 42(6):1062–1064CrossRefPubMed

Fourrier F (2012) Severe sepsis, coagulation, and fibrinolysis: dead end or one way? Crit Care Med 40:2704–2708CrossRefPubMed

Engelmann B, Massberg S (2013) Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 13:34–45CrossRefPubMed

Levi M (2015) Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality. J Thromb Haemost 13:505–507CrossRefPubMed

Fourrier F, Jourdain M, Tournois A, Caron C, Goudemand J, Chopin C (1995) Coagulation inhibitor substitution during sepsis. Intensive Care Med 21(Suppl 2):S264–S268CrossRefPubMed

Wang C, Chi C, Guo L, Wang X, Guo L, Sun J, Sun B, Liu S, Chang X, Li E (2014) Heparin therapy reduces 28-day mortality in adult severe sepsis patients: a systematic review and meta-analysis. Crit Care 18(5):563CrossRefPubMedPubMedCentral

Gando S, Saitoh D, Ishikura H, Ueyama M, Otomo Y, Oda S, Kushimoto S, Tanjoh K, Mayumi T, Ikeda T, Iba T, Eguchi Y, Okamoto K, Ogura H, Koseki K, Sakamoto Y, Takayama Y, Shirai K, Takasu O, Inoue Y, Mashiko K, Tsubota T, Endo S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group for the JDICAT (2013) A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis. Crit Care 17(6):R297CrossRefPubMedPubMedCentral

Yamakawa K, Aihara M, Ogura H, Yuhara H, Hamasaki T, Shimazu T (2015) Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis. J Thromb Haemost 13(4):508–519CrossRefPubMed

Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA, Group OTS (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290:238–247CrossRefPubMed

10.

Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gardlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD, PROWESS-SHOCK Study Group (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366(22):2055–2064CrossRefPubMed

11.

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup (2013) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRefPubMed

12.

Umemura Y, Yamakawa K (2016) Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost 14(3):518–530CrossRefPubMed

13.

Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699–709CrossRefPubMed

14.

Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2(11):1924–1933CrossRefPubMed

15.

Iba T, Di Nisio M, Thachil J, Wada H, Asakura H, Sato K, Kitamura N, Saitoh D (2016) Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity. Crit Care 20:287CrossRefPubMedPubMedCentral

16.

Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, Hoste E, Levy H, Hirman J, Levi M, Daga M, Kutsogiannis DJ, Crowther M, Bernard GR, Devriendt J, Puigserver JV, Blanzaco DU, Esmon CT, Parrillo JE, Guzzi L, Henderson SJ, Pothirat C, Mehta P, Fareed J, Talwar D, Tsuruta K, Gorelick KJ, Osawa Y, Kaul I (2013) A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med 41:2069–2079CrossRefPubMed

17.

Delabranche X, Quenot J, Lavigne T, Mercier E, François B, Severac F, Grunebaum L, Mehdi M, Zobairi F, Toti F, Meziani F, Boisramé-Helms J, Clinical Research in Intensive Care and Sepsis Network (2016) Early detection of disseminated intravascular coagulation during septic shock: a multicentre prospective study. Crit Care Med 44:e930–e939CrossRefPubMed

Title: Should all patients with sepsis receive anticoagulation? Yes
Authors: Ferhat Meziani
Satoshi Gando
Jean-Louis Vincent
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 3/2017
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-016-4621-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Should all patients with sepsis receive anticoagulation? Yes

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2017

Late-onset moderate to severe acute respiratory distress syndrome is associated with shorter survival and higher mortality: a two-stage association study

Peripheral VA-ECMO venous cannulation: which side for the femoral cannula?

Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines

Role of D-Dimer testing in venous thromboembolism with concomitant renal insufficiency in critical care

Understanding biofilm formation in intravascular device-related infections

Parental presence in Italian pediatric intensive care units: a reappraisal of current visiting policies